OnabotulinumtoxinA (BOTOX®)A Review of its Use in the Prophylaxis of Headaches in Adults with Chronic Migraine

被引：0
作者：
James E. Frampton
机构：
[1] Adis,
来源：
Drugs | 2012年 / 72卷
关键词：
Migraine; Topiramate; Chronic Migraine; Medication Overuse; OnabotulinumtoxinA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This article reviews the pharmacology, therapeutic efficacy and tolerability profile of intramuscularly injected onabotulinumtoxinA (onaBoNTA; BOTOX®) for headache prophylaxis in adults with chronic migraine, with a focus on UK labelling for the drug. The pharmacological actions of onaBoNTA include a direct antinociceptive (analgesic) effect; while not fully understood, the mechanism of action underlying its headache prophylaxis effect in chronic migraine is presumed to involve inhibition of peripheral and central sensitization in trigemino-vascular neurones.
引用
收藏
页码：825 / 845
页数：20
相关论文
共 50 条
  • [41] A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches
    Jacquelin Peck
    Ivan Urits
    Justin Zeien
    Shelby Hoebee
    Mohammad Mousa
    Hamed Alattar
    Alan D. Kaye
    Omar Viswanath
    Current Pain and Headache Reports, 2020, 24
  • [42] A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches
    Peck, Jacquelin
    Urits, Ivan
    Zeien, Justin
    Hoebee, Shelby
    Mousa, Mohammad
    Alattar, Hamed
    Kaye, Alan D.
    Viswanath, Omar
    CURRENT PAIN AND HEADACHE REPORTS, 2020, 24 (05)
  • [43] The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta-analysis
    Lindsay, Rebecca
    Kalifa, Amira
    Kuziek, Jonathan
    Kabbouche, Marielle
    Hershey, Andrew D.
    Orr, Serena L.
    HEADACHE, 2024, 64 (10): : 1200 - 1216
  • [44] Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
    F Ahmed
    M Khalil
    V Quarshie
    The Journal of Headache and Pain, 2013, 14
  • [45] Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
    Ahmed, F.
    Khalil, M.
    Quarshie, V.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [46] FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
    Rothrock, John F.
    Adams, Aubrey Manack
    Lipton, Richard B.
    Silberstein, Stephen D.
    Jo, Esther
    Zhao, Xiang
    Blumenfeld, Andrew M.
    HEADACHE, 2019, 59 (10): : 1700 - 1713
  • [47] Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study
    Katja Kollewe
    Charly Gaul
    Astrid Gendolla
    Katherine Sommer
    The Journal of Headache and Pain, 2021, 22
  • [48] Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study
    Kollewe, Katja
    Gaul, Charly
    Gendolla, Astrid
    Sommer, Katherine
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01)
  • [49] Association of Helicobacter pylori with migraine headaches and the effects of this infection and its eradication on the migraine characteristics in adults: A comprehensive systematic review and meta-analysis
    Bawand, Rashed
    Ghiasian, Masoud
    Samadyan, Mustapha
    Qaderi, Sorush
    HELICOBACTER, 2023, 28 (05)
  • [50] REAL-LIFE USE OF ONABOTULINUMTOXINA FOR SYMPTOM RELIEF IN PATIENTS WITH CHRONIC MIGRAINE: REPOSE STUDY GERMAN POPULATION
    Kollewe, Katja
    Gaul, Charly
    Gendolla, Astrid
    Sommer, Katherine
    TOXICON, 2021, 190 : S41 - S42
12345